StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Monday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.25 on Monday. The stock has a 50-day simple moving average of $1.37 and a 200 day simple moving average of $1.36. The stock has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. Global Cord Blood has a 12-month low of $2.03 and a 12-month high of $5.50.
Global Cord Blood Company Profile
Featured Articles
- Five stocks we like better than Global Cord Blood
- What is the Hang Seng index?
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is a Stock Market Index and How Do You Use Them?
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is Forex and How Does it Work?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.